BRCA2 and posterior cortical atrophy: When BRCA2 mutations were grouped according to the narrow definition of the OCCR (c.3847–c.6275) [2], [22] the difference in PCa risk for mutations within and outside the OCCR was attenuated (HR 0.42, 95% CI 0.16–1.09; Table 3).